Drug Deal Disclosure Act Legislation by Sen. Wyden Analyzed
Bill Intros-Senate
Copyright © Targeted News Service, 2026
Copyright © Targeted News Service, 2026
2026-05-06
Bailey Malota
WASHINGTON, May 6 -- The Drug Deal Disclosure Act, originally introduced by Sen. Ron Wyden, D-OR, on April 21, 2026, has been analyzed by the Congressional Research Service. This legislation aims to mandate the Department of Health and Human Services (HHS) to publicly disclose a wide range of documents and communications related to most favored nation pricing agreements and other confidential drug pricing deals made with manufacturers.
In an effort to enhance transparency in pharmac . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, May 6 -- The Drug Deal Disclosure Act, originally introduced by Sen. Ron Wyden, D-OR, on April 21, 2026, has been analyzed by the Congressional Research Service. This legislation aims to mandate the Department of Health and Human Services (HHS) to publicly disclose a wide range of documents and communications related to most favored nation pricing agreements and other confidential drug pricing deals made with manufacturers.
In an effort to enhance transparency in pharmac . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com